// Evidence Grader
Claim grades, A through F
Every major genomics claim in this course gets a transparent grade — from clinically established interventions to outright misleading marketing. Use this dashboard to audit what's settled, what's preliminary, and what's hype.
A
Clinically established
B
Supported, context-specific
C
Promising, preliminary
D
Plausible, unproven
E
Popular, weak support
F
Misleading or false
Filtered:← Back to module
F
Germline CRISPR editing of human embryos for medical indications is safe and ready for clinical use
He Jiankui case was scientifically and ethically condemned; no consensus body endorses germline editing for clinical use.
Module 09 · CRISPR Therapeutics: From Casgevy to In Vivo →